| Home | E-Submission | Sitemap | Editorial Office
top_img
   
REVIEW
Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues
With the enactment of the ‘Act on Decisions on Life-Sustaining Treatment for Patients in Hospice and Palliative Care or at the End of Life’ (Act No. 14013) in Korea, there is growing concern about the practicality of this law. In this review, we discuss definitions, ethics, a...
ORIGINAL ARTICLE
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
Background/Aims: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS) of MET compared to sorafenib for advanced hepatocellular c...
ORIGINAL ARTICLE
Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma
Background/Aims: The association between the kinesin family member 1B (KIF1B) gene polymorphism and the risk of hepatitis B virus-related hepatocellular carcinoma (HCC) has been investigated in many peer-reviewed studies. However, scholars have failed to replicate these results ...
Current Issue
Volume 23(2); Jun 2017
Volume 23(1); March 2017
Volume 22(4); December 2016
Volume 22(3); September 2016
Volume 22(2); June 2016
RSS feed
  • Most-cited are based on citations from 2015 ~ 2017.

    A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
    Su Jong Yu
    Clin Mol Hepatol.2016;22(1):7-17.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.7
                                     Cited By 21
    KASL clinical practice guidelines: management of chronic hepatitis B
    Clin Mol Hepatol.2016;22(1):18-75.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.18
                                     Cited By 20
    Hepatitis C virus-induced hepatocellular carcinoma
    Nicolas Goossens, Yujin Hoshida
    Clin Mol Hepatol.2015;21(2):105-114.   Published online June 26, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.2.105
                                     Cited By 19
    Personalized management of cirrhosis by non-invasive tests of liver fibrosis
    Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong
    Clin Mol Hepatol.2015;21(3):200-211.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.200
                                     Cited By 12
    The mutational landscape of hepatocellular carcinoma
    Ju-Seog Lee
    Clin Mol Hepatol.2015;21(3):220-229.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.220
                                     Cited By 12
    Clinical implications of advances in liver regeneration
    Yong Jin Kwon, Kyeong Geun Lee, Dongho Choi
    Clin Mol Hepatol.2015;21(1):7-13.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.7
                                     Cited By 12
    Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
    Yoon Ok Jang, Baek Gyu Jun, Soon Koo Baik, Moon Young Kim, Sang Ok Kwon
    Clin Mol Hepatol.2015;21(2):141-149.   Published online June 26, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.2.141
                                     Cited By 9
    The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
    In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
    Clin Mol Hepatol.2015;21(1):32-40.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.32
                                     Cited By 9
    Personalized treatment of hepatitis B
    Anna S. Lok
    Clin Mol Hepatol.2015;21(1):1-6.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.1
                                     Cited By 8
    New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
    Hyun Young Woo, Jeong Heo
    Clin Mol Hepatol.2015;21(2):115-121.   Published online June 26, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.2.115
                                     Cited By 7
    Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase
    Yasuko Iwakiri
    Clin Mol Hepatol.2015;21(4):319-325.   Published online December 24, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.4.319
                                     Cited By 6
    The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
    Goh Eun Chung, Donghee Kim, Min-Sun Kwak, Jong In Yang, Jeong Yoon Yim, Seon Hee Lim, Mustafa Itani
    Clin Mol Hepatol.2016;22(1):146-151.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.146
                                     Cited By 6
    Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir
    Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim
    Clin Mol Hepatol.2015;21(1):24-31.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.24
                                     Cited By 5
    Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
    Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park
    Clin Mol Hepatol.2015;21(3):279-286.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.279
                                     Cited By 5
    Imaging findings of mimickers of hepatocellular carcinoma
    Tae Kyoung Kim, Eunchae Lee, Hyun-Jung Jang
    Clin Mol Hepatol.2015;21(4):326-343.   Published online December 24, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.4.326
                                     Cited By 5
    Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
    Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa
    Clin Mol Hepatol.2015;21(1):41-48.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.41
                                     Cited By 5
    Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
    Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong
    Clin Mol Hepatol.2015;21(1):49-59.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.49
                                     Cited By 5
    KASL clinical practice guidelines: management of hepatitis C
    The Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol.2016;22(1):76-139.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.76
                                     Cited By 5
    Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
    Jung Gil Park
    Clin Mol Hepatol.2015;21(3):287-294.   Published online September 30, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.3.287
                                     Cited By 4
    Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient
    Jin Ok Kim, Dae Won Jun, Hye Jin Tae, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon, Joon Soo Hahm
    Clin Mol Hepatol.2015;21(1):85-88.   Published online March 25, 2015     
    DOI: https://doi.org/10.3350/cmh.2015.21.1.85
                                     Cited By 4
  • Editorial Office
    The Korean Association for the Study of the Liver
    Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
    TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © The Korean Association for the Study of the Liver. All rights reserved.